In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exposition, which examined the use of obinutuzumab in patients with thrombotic ...
Kamada (NASDAQ:KMDA – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a report released on Friday,Benzinga reports. They presently have a $11.00 price target on the ...